What You Should Know:
– A significant 87% of digital health investors stated that generative AI solutions have influenced their investment strategies, with nearly 1 out of 5 respondents indicating that it is significantly affecting their strategy, according to the results of an online survey from GSR Ventures.
– GSR Ventures, an early-stage digital health investment firm with over $3.5B in assets under management, conducted an online poll in September 2023 with over 40 participants from leading firms in the investment community. The survey covered topics such as deal volume, valuations, industry opportunities, and sectors of opportunity for startups.
Key Findings of the report include:
– Investment Trends: About 62.5% of investors expect to make the same number or more tech investments for the rest of 2023 compared to 2022.
– Lower Valuation Expectations: Most investors anticipate lower valuations for seed stage, Series A, and Series B companies, with decreases of 20% or more compared to 2022. The majority expect this trend to continue for the remainder of 2023.
– Promising Sectors: According to 55% of investors, the oncology specialty holds the most promise for startups, followed by cardiovascular care (37.5%). However, ophthalmology is seen as offering the least opportunity by nearly one-third (31%) of investors.
– Challenges and Opportunities: The shortage and burnout crisis among healthcare providers are seen as the most significant problem-solving opportunity for startup companies by 50% of investors, followed by changing reimbursement models at 26.3%.
“We expected that generative AI innovations had impacted the digital health investment community and our poll results certainly confirmed it, with nearly 1 out of 5 respondents attesting that it is ‘significantly’ influencing their strategy,” said Justin Norden, MD, MBA, a partner at GSR Ventures and adjunct professor at Stanford Medicine where he teaches courses on the subject to medical students. “It will be exciting to witness over the remainder of 2023 into 2024 the many new generative AI healthcare startups that enter the market. Hopefully, investor enthusiasm drives greater adoption of such technologies across an industry that would massively benefit from greater automation and efficiency.”
To review the full survey results, click here.
